Molecular Data Inc. (NASDAQ: MKD) started the day on January 10, 2022, with a price increase of 4.19% at $0.22. During the day, the stock rose to $0.225 and sunk to $0.2011 before settling in for the price of $0.21 at the close. Taking a more long-term approach, MKD posted a 52-week range of $0.18-$2.23.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -51.20%. This publicly-traded company’s shares outstanding now amounts to $116.05 million, simultaneously with a float of $89.44 million. The organization now has a market capitalization sitting at $30.93 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2716, while the 200-day Moving Average is $0.5766.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 189 workers. It has generated 5,823,137 per worker during the last fiscal year. Meanwhile, its income per employee was -251,431. The stock had 49.59 Receivables turnover and 12.55 Total Asset turnover. For the Profitability, stocks gross margin was -0.13, operating margin was -4.36 and Pretax Margin of -4.28.
Molecular Data Inc. (MKD) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Chemicals Industry. Molecular Data Inc.’s current insider ownership accounts for 10.08%, in contrast to 5.50% institutional ownership.
Molecular Data Inc. (MKD) Earnings and Revenue Records
This company achieved a net margin of -4.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Molecular Data Inc.’s EPS decrease for this current 12-month fiscal period is -51.20%.
Molecular Data Inc. (NASDAQ: MKD) Trading Performance Indicators
Let’s observe the current performance indicators for Molecular Data Inc. (MKD). It’s Quick Ratio in the last reported quarter now stands at 0.90. The Stock has managed to achieve an average true range (ATR) of 0.02. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.04.
In the same vein, MKD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.34.
Technical Analysis of Molecular Data Inc. (MKD)
If we take a close look at the recent performances of Molecular Data Inc. (NASDAQ: MKD), its last 5-days Average volume was 6.12 million that shows plunge from its year to date volume of 6.57 million. During the previous 9 days, stock’s Stochastic %D was recorded 44.20% While, its Average True Range was 0.0211.
Raw Stochastic average of Molecular Data Inc. (MKD) in the period of the previous 100 days is set at 10.57%, which indicates a major fall in contrast to 50.37% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 77.27% that was lower than 108.22% volatility it exhibited in the past 100-days period.